Abstract
In an almost soul-searching analysis of the changing patterns and practices of medical consumption in India, seen best as the dense point between the doctor and the patient, this chapter journeys through the complex world of organized medical practices, norms and technologies set almost always by the developed and influential West. That such growing emphases upon and practice of evidence-based consultation, diagnosis, treatment and, importantly, mode of payment have undermined the urgency and mechanism of reaching medical facilities to the huge number of poor and geographically disadvantaged population remain a key concern in relooking global standards critically. The discrediting of the individualized doctor–patient interaction—that has been drawing upon traditional knowledge, experiences and sensitivity to the local conditions—has been an unintended (maybe) consequence of bringing standards to the Indian medical consumption scenario. A particularly disturbing aspect has been the gradual derecognition of the potential of and encouragement due to public provisioning of technological leadership that could set different but more relevant medical standards.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Azoulay P (2004) Agents of embeddedness. NBER Working Paper No. w10142. http://www.nber.org/papers/w10142
Banerjee P (2004) The Indian software industry: business strategy and dynamic coordination. Palgrave-Macmillan, Houndmills
Banerjee P (2007) Biomedical innovation in India. Har-Anand, New Delhi
Benoliel D (2004) Technological standards. California Law Rev 92
Berg M, Mol A (1998) Differences in medicine: unraveling practices, techniques, and bodies. Duke University Press, Durham
Berman P, Khan ME (1993) Paying for India’s health care. Sage, New Delhi
Bhat R, Verma BB, Reuben E (2001) An empirical analysis of district hospitals and grant-in-aid hospitals in Gujarat state of India. Indian Institute of Management, Ahmedabad
Bottazzi G, Dosi G, Lippi M, Pammolli F, Riccaboni M (2001) Innovation and corporate growth in the evolution of drug industry. Sant’Anna School of Advanced Studies, Pisa
Bourdieu P (1990) In other words: essays towards reflexive sociology. Stanford University Press, Stanford
Coase R (1990) The nature of the firm. In: Williamson OE (ed) Industrial organisation. Elgar, Aldershot, pp 3–22
Cockburn I, Henderson R, Stern S (1999) The diffusion of science-driven drug discovery: organizational change in pharmaceutical research. NBER Working Paper No. w7359. http://ww.nber.org/papers/ww7359
Coombs R, Harvey M, Tether B (2001) Analysing distributed innovation processes. CRIC discussion Paper 43. Centre for Research on Innovation & Competition, The University of Manchester, Manchester
Dasgupta M, Chen LC, Krishnan TN (eds) (1996) Health, poverty and development in India. Oxford University Press, New Delhi
Edmondson AC, Bohmer RM, Pisano GP (2000) Learning new technical and interpersonal routines in operating room teams: the case of minimally invasive cardiac surgery. Res Manag Group Teams 3:29–51
Frischmann B (2000) Innovation and institutions: rethinking the economics of US science and technology policy. Vanderbilt Law Rev 24:347
Galambos L, Sturchio JL (1996) The pharmaceutical industry in the twentieth century: a reappraisal of the sources of innovation. Hist Technol 13:83–100
Gambardella A (1995) Science and innovation: the US pharmaceutical industry during the 1980s. Cambridge University Press, Cambridge
Garceau O (1940) Organized medicine enforces its ‘Party Line’. Public Opin Quart 4(3):408–428
Lathwal OP, Banerjee A (2001) Availability and utilization of major equipment at district hospital, Gurgaon. J Acad Hosp Adm 13(2):23–28
Loasby BJ (2001) Industrial dynamics: why connections matter. DRUID Academy Winter Conference. http//www.druid.dk/conferences/winter2001/paper-winter/paper/loasby.pdf
Malerba F, Orsenigo L (2001) Towards a history friendly model of innovation, market structure and regulation in the dynamics of the pharmaceutical industry: the age of random screening. CESPRI, Milan
Marks HM (1997) The progress of experiment: science and therapeutic reform in the United States, 1900-1990. Cambridge University Press, Cambridge
Marmor TR, Thomas D (1972) Doctors, politics and pay disputes: ‘pressure group politics’ revisited. Br J Polit Sci 2(4):421–442
McKelvey M, Orsenigo L (2001) Pharmaceuticals as a sectoral innovation system. Chalmers University & CESPRI, Bocconi University
Nelson RR, Winter SG (1982) An evolutionary theory of economic change. Harvard University Press, Cambridge
Nelson RR, Winter SG (2002) Evolutionary theorizing in economics. J Econ Perspect 16(2):23–46
Nicholson S, Danzon PM, McCullough J (2002) Biotech-pharmaceutical alliances as a signal of asset and firm quality. NBER Working Paper No. w9007. http://www.nber.org/ papers/w9007
North DC (1990) Institutions, institutional change and economic performance. Cambridge University Press, Cambridge
Pammolli F, Riccaboni M (2000) On the nature of markets for technology: lessons from the pharmaceutical industry. (pammolli@unisi.it)
Powell WW (1996) Inter-organizational collaboration in the biotechnology industry. J Inst Theor Econ 152:197–215
Richardson GB (1972) The organization of industry. Econ J 82:883–896
Richardson GB (1996) Competition, innovation and the increasing returns. DRUID Working Paper No. 97-4. DRUID, Aalborg
Saha B, Banerjee P, Kakani RK (2011) Strategic thinking. Sage, New Delhi
Satterfield JM (2009) Toward a transdisciplinary model of evidence-based practice. Milbank Quart 87(2):368–390
Sykes RN (2000) New medicines: the practice of medicine and public policy. Stationery Office, London
Timmermans S, Berg M (1997) Standardization in action: achieving local universality through medical protocols. Soc Stud Sci 27(2):273–305
Timmermans S, Kolker ES (2004) Evidence-based medicine and the reconfiguration of medical knowledge. J Health Soc Behav Extra Issue 45:177–193
Williamson OE (1981) The modern corporation: origins, evolution, attributes. J Econ Lit 19:1537–1568
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer India
About this chapter
Cite this chapter
Banerjee, P. (2014). Medical Consumption and Clinical Practice: India at the Crossroads. In: Das, K. (eds) Globalization and Standards. India Studies in Business and Economics. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1994-1_8
Download citation
DOI: https://doi.org/10.1007/978-81-322-1994-1_8
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-1993-4
Online ISBN: 978-81-322-1994-1
eBook Packages: Business and EconomicsEconomics and Finance (R0)